vytaros 2 mg/g krem
recordati ireland limited - alprostadilum - krem - 2 mg/g
vytaros 3 mg/g krem
recordati ireland limited - alprostadilum - krem - 3 mg/g
entresto
novartis europharm limited - sacubitril, walsartanu - niewydolność serca - antagoniści angiotensyny ii, inne kombinacje, środki działające na układ renina leki - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, walsartanu - niewydolność serca - Środki działające na układ renina-angiotensyna - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
carteol lp 2% 20 mg/ml krople do oczu o przedłużonym uwalnianiu
dr gerhard mann chem. - pharm. fabrik gmbh - carteololi hydrochloridum - krople do oczu o przedłużonym uwalnianiu - 20 mg/ml
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - Środki przeciwwirusowe do użytku ogólnoustrojowego - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Środki przeciwnowotworowe - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - Środki przeciwnowotworowe - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.